合成路线1
【1】
Zhang GS, Yang XP, Ma, YQ, et aL. 2006. Method for preparation of Pregabalin and its intermediate. W0 2006136087.(本专利属于Nhwa Pharma Corporation, Peop Rep China) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(II) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(III) |
66601 |
diethyl 3-isobutylpentanedioate |
|
C13H24O4 |
详情 | 详情
|
(IV) |
26065 |
3-isobutylpentanedioic acid
|
|
C9H16O4 |
详情 |
详情
|
(V) |
66602 |
4-isobutylpiperidine-2,6-dione |
|
C9H15NO2 |
详情 | 详情
|
(VI) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|
合成路线2
【1】
Hu SH, Martinez CA, Tao JH et al. 2005. Preparation of pregabalin and related compounds. US 2005283023 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66603 |
ethyl 3-cyano-4,4-dimethylpentanoate |
|
C10H17NO2 |
详情 | 详情
|
(II) |
66604 |
potassium (3S)-3-cyano-2-(ethoxycarbonyl)-5-methylhexanoate |
|
C11H16KNO4 |
详情 | 详情
|
(III) |
66605 |
4-isobutyl-2-oxopyrrolidine-3-carboxylic acid |
|
C9H15NO3 |
详情 | 详情
|
合成路线3
【1】
Burk MJ,De Koning PD. Grote TM, et aL. 2003. An enantioselective synthesis of (s)-(+)-3-aminom-ethyl-5-methylhexanoic acid via asymmetric hydrogenation. J Org Chem, 68:5731~5734(本论文的作者为Subsidiary of The Dow Chemrcal Company. Dowpharma Chirotech Technology Ltd, Cambridge, UK) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66606 |
(S)-ethyl 3-cyano-4,4-dimethylpentanoate |
|
C10H17NO2 |
详情 | 详情
|
(II) |
66607 |
(S)-3-cyano-4,4-dimethylpentanoic acid |
|
C8H13NO2 |
详情 | 详情
|
合成路线4
【1】
Blazecka PG, Davidson JG,Zhang J. 2003. Process for preparing highly functionalized butyrolactams and amino acids. W0 2003093220(本专利属于Warner-Lambert Company LLC, USA) |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66608 |
3,4-dibromo-5-hydroxyfuran-2(5H)-one |
766-38-1 |
C4H2Br2O3 |
详情 | 详情
|
(II) |
66609 |
5-(benzyloxy)-3,4-dibromofuran-2(5H)-one |
|
C11H8Br2O3 |
详情 | 详情
|
(III) |
66610 |
5-(benzyloxy)-3-bromo-4-isobutylfuran-2(5H)-one |
|
C15H17BrO3 |
详情 | 详情
|
(IV) |
66611 |
5-(benzyloxy)-3-bromo-4-isobutyldihydrofuran-2(3H)-one |
|
C15H19BrO3 |
详情 | 详情
|
合成路线5
【1】
Chen A, Zhang JJ. 2005. Synthesis of Pregabalin. 中国医药工业杂志,35: 195~196 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26065 |
3-isobutylpentanedioic acid
|
|
C9H16O4 |
详情 |
详情
|
(II) |
26066 |
4-isobutyldihydro-2H-pyran-2,6(3H)-dione
|
|
C9H14O3 |
详情 |
详情
|
(III) |
66612 |
3-(2-(aminooxy)-2-oxoethyl)-5-methylhexanoic acid |
|
C9H17NO4 |
详情 | 详情
|
(IV) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|
合成路线6
1) The reaction of 4-methylpentanoic acid (I) with SOCl2 in refluxing chloroform gives the acyl chloride (II), which is condensed with the chiral oxazolidinone (III) by means of BuLi in THF, yielding the corresponding N-acyl derivative (IV). The regioselective alkylation of (IV) with benzyl bromoacetate (V) by means of LDA in THF affords the (S)-adduct (VI) with >95% e.e. purity. The elimination of the chiral auxiliary with LiOH and H2O2 gives the glutaric acid monoester (VII), which is reduced with BH3/SMe2 in THF, yielding compound (VIII). The reaction of (VIII) with tosyl chloride in pyridine yields the tosylate (IX), which is treated with sodium azide in DMSO, affording the azide (X). Finally, this compound is reduced and debenzylated with H2 over Pd/C in THF.
【1】
Bryans, J.S.; Wustrow, D.J.; 3-Substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999, 19, 2, 149.
|
【2】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【3】
Sobieray, D.M.; Hoekstra, M.S.; Schwindt, M.A.; et al.; Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org Process Res Dev 1997, 1, 1, 26.
|
【4】
Taylor, C.P.; Kanter, G.D.; Vartanian, M.G.; Yuen, P.; Enantioselective synthesis of PD144723: A potent stereospecific anticonvulsant. Bioorg Med Chem Lett 1994, 4, 6, 823.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25389 |
4-methylpentanoic acid
|
646-07-1 |
C6H12O2 |
详情 | 详情
|
(II) |
25390 |
4-methylpentanoyl chloride
|
38136-29-7 |
C6H11ClO |
详情 | 详情
|
(III) |
26040 |
(4R,5S)-4-methyl-5-phenyl-1,3-oxazolidin-2-one
|
|
C10H11NO2 |
详情 |
详情
|
(IV) |
26041 |
(4R,5S)-4-methyl-3-(4-methylpentanoyl)-5-phenyl-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(V) |
12869 |
benzyl 2-bromoacetate
|
5437-45-6 |
C9H9BrO2 |
详情 | 详情
|
(VI) |
26042 |
benzyl (3S)-5-methyl-3-[[(4R,5S)-4-methyl-2-oxo-5-phenyl-1,3-oxazolidin-3-yl]carbonyl]hexanoate
|
|
C25H29NO5 |
详情 |
详情
|
(VII) |
26043 |
(2S)-2-[2-(benzyloxy)-2-oxoethyl]-4-methylpentanoic acid
|
|
C15H20O4 |
详情 |
详情
|
(VIII) |
26044 |
benzyl (3S)-3-(hydroxymethyl)-5-methylhexanoate
|
|
C15H22O3 |
详情 |
详情
|
(IX) |
26045 |
benzyl (3S)-5-methyl-3-([[(4-methylphenyl)sulfonyl]oxy]methyl)hexanoate
|
|
C22H28O5S |
详情 |
详情
|
(X) |
26046 |
benzyl (3S)-3-(azidomethyl)-5-methylhexanoate
|
|
C15H21N3O2 |
详情 |
详情
|
合成路线7
2) The reaction of 4-methylpentanoic acid (I) with SOCl2 in refluxing chloroform gives the acyl chloride (II), which is condensed with the chiral oxazolidinone (III) by means of BuLi in THF, yielding the corresponding N-acyl derivative (IV). The regioselective alkylation of (IV) with tert-butyl bromoacetate (XI) by means of LDA in THF affords the (S)-adduct (XII). The elimination of the chiral auxiliary with LiOH and H2O2 gives the glutaric acid monoester (XIII), which is reduced with BH3/SMe2 in THF, yielding compound (XIV). The reaction of (XIV) with tosyl chloride in pyridine yields the tosylate (XV), which is treated with sodium azide in DMSO, affording the azide (XVI). The hydrolysis of the tert-butyl group of (XVI) affords the free acid (XVII), which is reduced with H2 over Pd/C.
【1】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【2】
Sobieray, D.M.; Hoekstra, M.S.; Schwindt, M.A.; et al.; Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org Process Res Dev 1997, 1, 1, 26.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25389 |
4-methylpentanoic acid
|
646-07-1 |
C6H12O2 |
详情 | 详情
|
(II) |
25390 |
4-methylpentanoyl chloride
|
38136-29-7 |
C6H11ClO |
详情 | 详情
|
(III) |
26040 |
(4R,5S)-4-methyl-5-phenyl-1,3-oxazolidin-2-one
|
|
C10H11NO2 |
详情 |
详情
|
(IV) |
26041 |
(4R,5S)-4-methyl-3-(4-methylpentanoyl)-5-phenyl-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(XI) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(XII) |
26047 |
tert-butyl (3S)-5-methyl-3-[[(4R,5S)-4-methyl-2-oxo-5-phenyl-1,3-oxazolidin-3-yl]carbonyl]hexanoate
|
|
C22H31NO5 |
详情 |
详情
|
(XIII) |
25393 |
(2R)-2-[2-(tert-butoxy)-2-oxoethyl]-4-methylpentanoic acid
|
|
C12H22O4 |
详情 |
详情
|
(XIV) |
26048 |
tert-butyl (3S)-3-(hydroxymethyl)-5-methylhexanoate
|
|
C12H24O3 |
详情 |
详情
|
(XV) |
26049 |
tert-butyl (3S)-5-methyl-3-([[(4-methylphenyl)sulfonyl]oxy]methyl)hexanoate
|
|
C19H30O5S |
详情 |
详情
|
(XVI) |
26050 |
tert-butyl (3S)-3-(azidomethyl)-5-methylhexanoate
|
|
C12H23N3O2 |
详情 |
详情
|
(XVII) |
26051 |
(3S)-3-(azidomethyl)-5-methylhexanoic acid
|
|
C8H15N3O2 |
详情 |
详情
|
合成路线8
3) The reaction of diethyl malonate (XVIII) with 3-methylbutanal (XIX) by means of dipropylamine in acetic acid gives the corresponding 2-(3-methylbutylidene)malonate derivative (XX), which is treated with KCN to yield the corresponding addition compound (XXI). The decarboxylative hydrolysis of (XXI) with KOH affords 3-cyano-5-methylhexanoic acid (XXII), which is reduced with H2 over Ni to yield racemic pregabalin (XXIII). Finally, this racemate is submitted to optical resolution with (S)-(+)-mandelic acid.
【1】
Bryans, J.S.; Wustrow, D.J.; 3-Substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999, 19, 2, 149.
|
【2】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【3】
Mulhern, T.; Sobieray, D.M.; Huckabee, B.K.; Grote, T.M.; Titus, R.D. (Pfizer Inc.); Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid. WO 9640617 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XIX) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XX) |
26053 |
diethyl 2-(3-methylbutylidene)malonate
|
|
C12H20O4 |
详情 |
详情
|
(XXI) |
26054 |
diethyl 2-(1-cyano-3-methylbutyl)malonate
|
|
C13H21NO4 |
详情 |
详情
|
(XXII) |
26055 |
3-cyano-5-methylhexanoic acid
|
|
C8H13NO2 |
详情 |
详情
|
(XXIII) |
26056 |
3-(aminomethyl)-5-methylhexanoic acid
|
130912-52-6 |
C8H17NO2 |
详情 | 详情
|
合成路线9
4) The deamination of L-leucine (XXIV) with NaNO2, NaBr and H2SO4 gives 2(S)-bromo-4-methylpentanoic acid (XXV), which is esterified with tert-butyl acetate and BF3.AcOH to yield the tert-butyl ester (XXVI). The condensation of (XXVI) with the sodium salt of diethyl malonate affords the substituted malonic ester (XXVII), which is selectively hydrolyzed at the tert-butyl ester group with formic acid, giving the monoacid (XXVIII). The decarboxylative reduction of (XXVIII) with BH3 and SMe2 provides 3(S)-isobutylbutano-4-lactone (XXIX). Lactone (XXIX) is submitted to ring opening by treatment with trimethylsilyl iodide in ethanol, yielding 3(S)-(iodomethyl)-5-methylhexanoic acid ethyl ester (XXX). The reaction of (XXX) with sodium azide yields azide (XXXI), which is hydrolyzed with KOH in ethanol/water to afford the free acid (XVII). Finally, this compound is reduced to pregabalin by treatment with H2 over Pd/C.
【1】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【2】
Sobieray, D.M.; Hoekstra, M.S.; Schwindt, M.A.; et al.; Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org Process Res Dev 1997, 1, 1, 26.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVII) |
26051 |
(3S)-3-(azidomethyl)-5-methylhexanoic acid
|
|
C8H15N3O2 |
详情 |
详情
|
(XXIV) |
26057 |
L-Leucine
|
61-90-5 |
C6H13NO2 |
详情 | 详情
|
(XXV) |
26058 |
(2S)-2-bromo-4-methylpentanoic acid
|
|
C6H11BrO2 |
详情 |
详情
|
(XXVI) |
26059 |
tert-butyl (2S)-2-bromo-4-methylpentanoate
|
|
C10H19BrO2 |
详情 |
详情
|
(XXVII) |
26060 |
2-(tert-butyl) 1,1-diethyl (2S)-4-methyl-1,1,2-pentanetricarboxylate
|
|
C17H30O6 |
详情 |
详情
|
(XXVIII) |
26061 |
(2S)-2-[2-ethoxy-1-(ethoxycarbonyl)-2-oxoethyl]-4-methylpentanoic acid
|
|
C13H22O6 |
详情 |
详情
|
(XXIX) |
26062 |
(4S)-4-isobutyldihydro-2(3H)-furanone
|
|
C8H14O2 |
详情 |
详情
|
(XXX) |
26063 |
ethyl (3S)-3-(iodomethyl)-5-methylhexanoate
|
|
C10H19IO2 |
详情 |
详情
|
(XXXI) |
26064 |
ethyl (3S)-3-(azidomethyl)-5-methylhexanoate
|
|
C10H19N3O2 |
详情 |
详情
|
合成路线10
5) The condensation of 3-methylbutanal (XIX) with cyanoacetic acid ethyl ester (XXXII) or cyanoacetamide (XXXIII) by means of dipropylamine in refluxing hexane, followed by treatment with refluxing 6N HCl, gives 3-isobutylglutaric acid (XXXIV). This compound is converted into the corresponding anhydride (XXXV) by treatment with refluxing acetic anhydride. The reaction of the anhydride (XXXV) with NH4OH affords the glutaramic amide (XXXVI), which is submitted to optical resolution with (R)-(+)-1-phenylethylamine, yielding the (S)-enantiomer (XXXVII). Finally, this compound is submitted to a Hoffmann degradation with Br2/NaOH.
【1】
Newhouse, B.J.; Ibrahim, P.; Burgess, L.E.; et al.; Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci USA 1999, 96, 15, 8348.
|
【2】
Sobieray, D.M.; Hoekstra, M.S.; Schwindt, M.A.; et al.; Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org Process Res Dev 1997, 1, 1, 26.
|
【3】
Huckabee, B.K.; Sobieray, D.M. (Pfizer Inc.); Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid. WO 9638405 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIX) |
26052 |
3-methylbutanal
|
590-86-3 |
C5H10O |
详情 | 详情
|
(XXXII) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(XXXIII) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(XXXIV) |
26065 |
3-isobutylpentanedioic acid
|
|
C9H16O4 |
详情 |
详情
|
(XXXV) |
26066 |
4-isobutyldihydro-2H-pyran-2,6(3H)-dione
|
|
C9H14O3 |
详情 |
详情
|
(XXXVI) |
26067 |
3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
|
|
C9H17NO3 |
详情 |
详情
|
(XXXVII) |
26068 |
(3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
|
|
C9H17NO3 |
详情 |
详情
|
合成路线11
An asymmetric synthesis of pregabalin has been reported: Condensation of isobutyraldehyde (I) with acrylonitrile (II) by means of DBU and 2,6-di-tert-butyl-4- methylphenol (DBP) gives 3-hydroxy-4-methyl-2-methylenepentanenitrile (III), which is acylated with AcCl or Ac2O and pyridine to yield the acetate (IV). The carboxylation of (IV) by means of Pd(OAc)2, PPh3, CO and EtOH affords 3-cyano-4-methyl-3-hexenoic acid ethyl ester (Va-b), which is hydrolyzed with KOH in THF/water to provide the corresponding carboxylic acid potassium salt (VIa-b). Acidification of (VIa-b) with HCl, followed by reaction with tert-butylamine gives the corresponding salt (VIIa-b), which is reduced with H2 over a chiral (R,R)-rhodium catalyst [(R,R)-Rh] in THF/water to yield (S)-3-cyano-5-methylhexanoic acid butylammonium salt (VIII). Finally, the CN group of (VIII) is reduced with H2 over a sponge-Ni catalyst in basic (KOH) ethanol.
Alternatively, intermediate (VIa-b) can be reduced with H2 over a chiral (R,R)-rhodium catalyst [(R,R)-Rh] in THF/water to yield (S)-3-cyano-5-methylhexanoic acid potassium salt (IX). Finally, the CN group of (IX) is reduced with H2 over a sponge-Ni catalyst in basic (KOH) ethanol.
【1】
Mich, T.F.; Goel, O.P.; Mulhern, T.A.; Burk, M.J.; Hoekstra, M.S.; Ramsden, J.A. (Pfizer Inc.); Asymmetric synthesis of pregabalin. WO 0155090 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(Va) |
52664 |
ethyl 3-cyano-5-methyl-3-hexenoate
|
|
C10H15NO2 |
详情 |
详情
|
(Vb) |
52665 |
ethyl 3-cyano-5-methyl-3-hexenoate
|
|
C10H15NO2 |
详情 |
详情
|
(VIa) |
52666 |
potassium 3-cyano-5-methyl-3-hexenoate
|
|
C8H10KNO2 |
详情 |
详情
|
(VIb) |
52667 |
potassium 3-cyano-5-methyl-3-hexenoate
|
|
C8H10KNO2 |
详情 |
详情
|
(VIIa) |
52668 |
2-methyl-2-propanaminium 3-cyano-5-methyl-3-hexenoate
|
|
C12H22N2O2 |
详情 |
详情
|
(VIIb) |
52669 |
2-methyl-2-propanaminium 3-cyano-5-methyl-3-hexenoate
|
|
C12H22N2O2 |
详情 |
详情
|
(I) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(II) |
10847 |
Acrylonitrile
|
107-13-1 |
C3H3N |
详情 | 详情
|
(III) |
52660 |
2-(1-hydroxy-2-methylpropyl)-2-propenenitrile
|
|
C7H11NO |
详情 |
详情
|
(IV) |
52661 |
2-cyano-1-(1-methylethyl)-2-propenyl acetate
|
|
C9H13NO2 |
详情 |
详情
|
(VIII) |
52662 |
2-methyl-2-propanaminium 3-cyano-5-methylhexanoate
|
|
C12H24N2O2 |
详情 |
详情
|
(IX) |
52663 |
potassium 3-cyano-5-methylhexanoate
|
|
C8H12KNO2 |
详情 |
详情
|